Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Clinicopathological Features and Prognostic Factors of DLBCL].
Lin JY, Zheng YB, He HM, Wang JS, Yang Y, Chen DG, Chen Y. Lin JY, et al. Among authors: wang js. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):779-783. doi: 10.7534/j.issn.1009-2137.2018.03.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29950219 Chinese.
[Analysis of the Predictive Value of EZH2 Expression Level on the Clinical Efficacy and Long-term Prognosis of Patients with Primary Gastrointestinal Diffuse Large B-cell Lymphoma].
Lin JY, Zheng YB, He HM, Wang JS, Yang Y, Chen DG, Zou SP, Wang C. Lin JY, et al. Among authors: wang c, wang js. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Jun;29(3):725-730. doi: 10.19746/j.cnki.issn.1009-2137.2021.03.012. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34105464 Chinese.
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study.
Zhao P, Zhao S, Huang C, Li Y, Wang J, Xu J, Li L, Qian Z, Li W, Zhou S, Qiu L, Liu X, Chen Y, Jiang Y, Zheng Y, Chen D, Zhou H, Gao Y, Zhang Q, Zhang H. Zhao P, et al. Hematol Oncol. 2025 Jan;43(1):e70017. doi: 10.1002/hon.70017. Hematol Oncol. 2025. PMID: 39641321
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.
Liu J, Gao F, Zhang T, Wang J, Li Z, Liu L, Zhou H, Zhang X, Sun X, Zhang W, Xu B, Su L, Wen S, Tao R, Bai O, Zou L, Li L, Qiu L, Qian Z, Zhou S, Song Y, Zhang Q, Wang X, Zhang H. Liu J, et al. Br J Haematol. 2024 Nov;205(5):1815-1824. doi: 10.1111/bjh.19770. Epub 2024 Sep 26. Br J Haematol. 2024. PMID: 39327747
2,381 results